Medscape has published a clinical feature on the impact of hirsutism and hair removal in transfeminine people, putting a familiar but under-discussed topic at the front of the specialty's news cycle. The article lands as dermatology clinics across the United States report steady demand for gender-affirming laser and electrolysis services.

The feature draws attention to a routine that shapes daily life for many patients. Facial and body hair remains a leading source of gender dysphoria. It also gates access to gender-affirming surgery, including vaginoplasty.

Hirsutism in transfeminine patients typically follows a male androgenic pattern. It reflects endogenous testosterone plus the residual terminal growth that often persists despite estrogen-based hormone therapy. Anti-androgens such as spironolactone and finasteride slow new growth. They rarely reverse established coarse hairs on the face, chest, or back.

What does hirsutism look like in this cohort?

Clinicians most often grade facial and body hair using a modified Ferriman-Gallwey score. The original tool counts nine androgen-sensitive sites, each scored from one to four. Scores above eight usually signal clinical hirsutism in women. Transfeminine patients often arrive with scores in the mid-teens or higher before any hormone therapy.

Hair density matters as much as distribution. Many patients describe hours of daily grooming. Shaving, depilatory creams, and threading offer short-term relief. None of them removes the follicle.

What hair removal methods does the feature weigh?

Most patients pursue a mix of laser hair reduction and electrolysis. Laser works best on dark, coarse follicles with strong pigment contrast. Electrolysis remains the only FDA-cleared method for permanent destruction of the follicle. It treats any hair color or skin type.

Alexandrite (755 nm) and diode (800 to 810 nm) lasers dominate most U.S. clinics. Nd:YAG (1064 nm) devices serve patients with darker skin phototypes, including Fitzpatrick IV through VI. Treatment courses typically run six to eight sessions spaced four to six weeks apart.

Why does pre-surgical hair removal matter?

For patients undergoing vaginoplasty, clearance of scrotal and penile skin is required. That tissue often becomes part of the neovaginal lining. Retained terminal hair can cause post-operative discomfort, hygiene problems, and revision surgery.

Electrolysis is the first choice for genital tissue because it permanently destroys each follicle. Laser cannot safely treat mucosal sites. Surgeons typically require three to six months of documented clearance before operating.

What does this mean for the dermatology office?

Dermatologists see transfeminine patients for hair removal more often than many practices acknowledge. A welcoming intake form, a trained laser operator, and a clear referral path to a medical electrologist all matter.

Insurance coverage remains uneven. Most U.S. insurers still classify facial and body hair removal as cosmetic. Patients pay out of pocket for multi-session laser courses that can exceed several thousand dollars over a year. A small but growing list of plans now covers pre-operative genital electrolysis when tied to a pending vaginoplasty.

Why does this matter beyond the clinic?

For transfeminine patients, hair removal is not vanity. It is often a daily safety decision. Visible stubble can trigger misgendering, harassment, or worse in public spaces. Many skip the gym, the pool, or the beach to avoid it.

Dermatologists who treat these patients sit at a clinical and a human crossroads. The laser handpiece is also a psychosocial tool. The treatment room is where dysphoria meets evidence-based care, and where a steady hand can ease a hard day.

The Medscape feature is a quiet reminder. Hirsutism management in transfeminine patients is core dermatology. Expect more research, clearer coding guidance, and more fellowship slots built around gender-affirming procedures in the years ahead.